310 related articles for article (PubMed ID: 9341115)
1. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
[TBL] [Abstract][Full Text] [Related]
4. Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter.
Wang Y; O'Neal KD; Yu-Lee L
Mol Endocrinol; 1997 Aug; 11(9):1353-64. PubMed ID: 9259325
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
[TBL] [Abstract][Full Text] [Related]
6. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
7. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
8. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
9. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5.
Fleenor DE; Freemark M
Endocrinology; 2001 Jul; 142(7):2805-10. PubMed ID: 11415999
[TBL] [Abstract][Full Text] [Related]
10. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
Aoki N; Matsuda T
J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
[TBL] [Abstract][Full Text] [Related]
11. Selective coupling of STAT factors to the mouse prolactin receptor.
Mayr S; Welte T; Windegger M; Lechner J; May P; Heinrich PC; Horn F; Doppler W
Eur J Biochem; 1998 Dec; 258(2):784-93. PubMed ID: 9874248
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.
Kazansky AV; Kabotyanski EB; Wyszomierski SL; Mancini MA; Rosen JM
J Biol Chem; 1999 Aug; 274(32):22484-92. PubMed ID: 10428824
[TBL] [Abstract][Full Text] [Related]
13. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
Carsol JL; Gingras S; Simard J
Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
[TBL] [Abstract][Full Text] [Related]
14. Association of 2',5'-oligoadenylate synthetase with the prolactin (PRL) receptor: alteration in PRL-inducible stat1 (signal transducer and activator of transcription 1) signaling to the IRF-1 (interferon-regulatory factor 1) promoter.
McAveney KM; Book ML; Ling P; Chebath J; Yu-Lee L
Mol Endocrinol; 2000 Feb; 14(2):295-306. PubMed ID: 10674401
[TBL] [Abstract][Full Text] [Related]
15. Multiple stat complexes interact at the interferon regulatory factor-1 interferon-gamma activation sequence in prolactin-stimulated Nb2 T cells.
Wang YF; Yu-Lee LY
Mol Cell Endocrinol; 1996 Jul; 121(1):19-28. PubMed ID: 8865162
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
[TBL] [Abstract][Full Text] [Related]
17. Biphasic transcriptional regulation of the interferon regulatory factor-1 gene by prolactin: involvement of gamma-interferon-activated sequence and Stat-related proteins.
Stevens AM; Wang YF; Sieger KA; Lu HF; Yu-Lee LY
Mol Endocrinol; 1995 Apr; 9(4):513-25. PubMed ID: 7659094
[TBL] [Abstract][Full Text] [Related]
18. Stat5b inhibits NFkappaB-mediated signaling.
Luo G; Yu-Lee L
Mol Endocrinol; 2000 Jan; 14(1):114-23. PubMed ID: 10628751
[TBL] [Abstract][Full Text] [Related]
19. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
Pezet A; Ferrag F; Kelly PA; Edery M
J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
